X-24210293-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_003410.4(ZFX):āc.1335A>Cā(p.Lys445Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000438 in 1,209,843 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000045 ( 0 hom., 5 hem., cov: 23)
Exomes š: 0.000044 ( 0 hom. 13 hem. )
Consequence
ZFX
NM_003410.4 missense
NM_003410.4 missense
Scores
3
6
8
Clinical Significance
Conservation
PhyloP100: 4.49
Genes affected
ZFX (HGNC:12869): (zinc finger protein X-linked) This gene on the X chromosome is structurally similar to a related gene on the Y chromosome. It encodes a member of the krueppel C2H2-type zinc-finger protein family. The full-length protein contains an acidic transcriptional activation domain (AD), a nuclear localization sequence (NLS) and a DNA binding domain (DBD) consisting of 13 C2H2-type zinc fingers. Studies in mouse embryonic and adult hematopoietic stem cells showed that this gene was required as a transcriptional regulator for self-renewal of both stem cell types, but it was dispensable for growth and differentiation of their progeny. Multiple alternatively spliced transcript variants encoding different isoforms have been identified, but the full-length nature of some variants has not been determined. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFX | NM_003410.4 | c.1335A>C | p.Lys445Asn | missense_variant | 10/10 | ENST00000304543.10 | NP_003401.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFX | ENST00000304543.10 | c.1335A>C | p.Lys445Asn | missense_variant | 10/10 | 5 | NM_003410.4 | ENSP00000304985.5 |
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111574Hom.: 0 Cov.: 23 AF XY: 0.000148 AC XY: 5AN XY: 33748
GnomAD3 genomes
AF:
AC:
5
AN:
111574
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
33748
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000218 AC: 4AN: 183515Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67945
GnomAD3 exomes
AF:
AC:
4
AN:
183515
Hom.:
AF XY:
AC XY:
0
AN XY:
67945
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000437 AC: 48AN: 1098269Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 13AN XY: 363623
GnomAD4 exome
AF:
AC:
48
AN:
1098269
Hom.:
Cov.:
31
AF XY:
AC XY:
13
AN XY:
363623
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000448 AC: 5AN: 111574Hom.: 0 Cov.: 23 AF XY: 0.000148 AC XY: 5AN XY: 33748
GnomAD4 genome
AF:
AC:
5
AN:
111574
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
33748
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.1335A>C (p.K445N) alteration is located in exon 11 (coding exon 7) of the ZFX gene. This alteration results from a A to C substitution at nucleotide position 1335, causing the lysine (K) at amino acid position 445 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;.;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;L;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;.;D;D;D
REVEL
Benign
Sift
Uncertain
D;.;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
0.80
.;.;P;P;.
Vest4
MutPred
0.66
.;.;Loss of catalytic residue at K445 (P = 0.0025);Loss of catalytic residue at K445 (P = 0.0025);.;
MVP
MPC
2.4
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at